Popular Hair Care Products Recalled for Potential Cancer-Causing Chemical

By Sarah King

Oct 25

Popular Hair Care Products Recalled for Potential Cancer-Causing Chemical

London-based consumer goods company, Unilever, is well known for its brands such as Dove, Suave, TRESemme, Bed Head and other hair and skincare products. The company recalled 19 of its products after the concern of the chemical, benzene, having the potential to cause cancer.

The 19 recalled items are aerosol dry shampoo products that were produced prior to October of 2021. Unilever states that there are no reports of cancer due to their product as of yet.

Benzene is a chemical that is also used in pesticides, plastics and dyes and can result in leukemia or blood cancers through inhalation, ingestion, or skin contact.

Retailers were notified to pull the items from shelves, but it is important to check your products to confirm you are not using a recalled item. The full list of recalled products can be found here.
Philadelphia and New Jersey Personal Injury Attorneys
The personal injury attorneys at Messa & Associates are experienced at handling personal injury cases involving serious injuries resulting from defective products. Our extremely skilled team of personal injury attorneys and medical experts is dedicated to ensuring you receive proper compensation for your personal injuries. If you have been injured by a defective product, or have endured any other type of personal injury, contact the personal injury attorneys at Messa & Associates for a free consultation. Call toll-free at 1-877-MessaLaw, or submit a free online inquiry.

The attorneys at Messa & Associates are experienced in handling product liability and other cases that result in injury or chronic illness including the following:
-$20 Million total settlement for clients injured as a result of ingestion of the diet drug Fen-Phen.
-$750,000 recovery in chemical exposure case resulting in brain cancer.
-Confidential settlement reached between plaintiff and a major American pharmaceutical company as part of a class action consumer fraud case relating to the company’s concealment of material information about the substandard and defective nature of certain over-the-counter medications, including their potentially harmful effects.

About the Author